Lenalidomide and Bicnu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lenalidomide (lenalidomide) and Bicnu (carmustine). Common drug interactions include myelodysplastic syndrome among females and polyneuropathy among males.

The phase IV clinical study analyzes what interactions people have when they take Lenalidomide and Bicnu. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

What is Bicnu?

Bicnu has active ingredients of carmustine. eHealthMe is studying from 1,135 Bicnu users. Check the latest studies of Bicnu.

On Jul, 17, 2026

35 people who take Lenalidomide and Bicnu together, and have interactions are studied.

Lenalidomide and Bicnu drug interactions.

What are the common drug interactions of Lenalidomide and Bicnu, by gender? *:

female:

Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
Lymphoma (cancer that begins in immune system cells)
Neoplasm progression (growth of tumour)
Second primary malignancy (after getting cure a cancer, a new cancer development)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Hypertension (high blood pressure)
Hypotension (abnormally low blood pressure)
Leukocytosis (increased white blood cells)

male:

Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
Lymphoma (cancer that begins in immune system cells)
Herpes zoster
Inflammation
Escherichia infection (bacterial infection by escherichia coli)
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal bacterial infection (infection of the stomach and intestines caused by bacteria)
Neoplasm progression (growth of tumour)
Septic shock (shock due to blood infection)

What are the common drug interactions of Lenalidomide and Bicnu, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
Lymphoma (cancer that begins in immune system cells)
Neoplasm progression (growth of tumour)

50-59:

Infection
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Escherichia infection (bacterial infection by escherichia coli)
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal bacterial infection (infection of the stomach and intestines caused by bacteria)
Lymphoma (cancer that begins in immune system cells)
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
Second primary malignancy (after getting cure a cancer, a new cancer development)
Septic shock (shock due to blood infection)

60+:

Infection
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Second primary malignancy (after getting cure a cancer, a new cancer development)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Urinary tract infection bacterial
Herpes zoster
Inflammation
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Hypertension (high blood pressure)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 18 people, 51.43%
Multiple Myeloma (cancer of the plasma cells): 15 people, 42.86%

* Approximation only. Some reports may have incomplete information.

Do you take Lenalidomide and Bicnu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously